CDER’s new proposal to withdraw the accelerated approval of Makena (HPC) was primarily based upon a sizable randomized demo that failed to verify the advantage of this drug to newborns or cut down the chance of PTB. https://ezekielgusc465723.wikicarrier.com/54894/the_2_minute_rule_for_mkena_com